Financhill
Sell
35

CMCM Quote, Financials, Valuation and Earnings

Last price:
$4.29
Seasonality move :
9.84%
Day range:
$4.20 - $4.30
52-week range:
$2.70 - $6.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
0.49x
Volume:
37.1K
Avg. volume:
49.7K
1-year change:
41.86%
Market cap:
$127.6M
Revenue:
$112.5M
EPS (TTM):
-$2.89
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $225M $121.5M $131.6M $94.6M $112.5M
Revenue Growth (YoY) -56.68% -45.99% 8.31% -28.09% 18.81%
 
Cost of Revenues $68.9M $39.9M $37.6M $32.8M $36.5M
Gross Profit $156.1M $81.6M $94M $61.9M $76M
Gross Profit Margin 69.38% 67.16% 71.43% 65.36% 67.57%
 
R&D Expenses $66M $32.8M $26.9M $25.2M $33.9M
Selling, General & Admin $166.3M $87.1M $102.9M $66.7M $81.8M
Other Inc / (Exp) $145.4M -$21M -$53M -$69.1M -$43.8M
Operating Expenses $233.1M $117.2M $127.6M $91.5M $115.6M
Operating Income -$77M -$35.6M -$33.6M -$29.7M -$39.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $73.6M -$52.6M -$81.3M -$90.1M -$77.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14.1M $2.1M -$3.7M -$6.2M $6.6M
Net Income to Company $59.6M -$54.7M -$77.5M -$84M --
 
Minority Interest in Earnings $807.8K $321.8K $1.1M -$1.3M -$2.2M
Net Income to Common Excl Extra Items $60.4M -$54.4M -$76.4M -$85.2M -$86.1M
 
Basic EPS (Cont. Ops) $2.10 -$1.91 -$2.69 -$2.89 -$2.90
Diluted EPS (Cont. Ops) $2.07 -$1.91 -$2.69 -$2.90 -$2.90
Weighted Average Basic Share $28.1M $28.6M $28.9M $29.5M $30.1M
Weighted Average Diluted Share $28.4M $28.6M $28.9M $29.5M $30.1M
 
EBITDA -$67M -$27.7M -$25.7M -$24.7M -$39.6M
EBIT -$77M -$35.6M -$33.6M -$29.7M -$39.6M
 
Revenue (Reported) $225M $121.5M $131.6M $94.6M $112.5M
Operating Income (Reported) -$77M -$35.6M -$33.6M -$29.7M -$39.6M
Operating Income (Adjusted) -$77M -$35.6M -$33.6M -$29.7M -$39.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $40M $27.9M -- $23.2M $33M
Revenue Growth (YoY) -53.96% -30.33% -- -16.6% 41.76%
 
Cost of Revenues $15.1M $11.5M -- $9.5M $8.9M
Gross Profit $24.9M $16.4M -- $13.8M $24M
Gross Profit Margin 62.15% 58.87% -- 59.21% 72.87%
 
R&D Expenses $10.5M $5.6M -- $5.5M $9.1M
Selling, General & Admin $24.2M $20.2M -- $16.7M $22.4M
Other Inc / (Exp) $17.6M -$53.1M -- -$42.2M -$37.2M
Operating Expenses $36M $24.4M -- $22.2M $31.6M
Operating Income -$11.2M -$8M -- -$8.5M -$7.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $6.7M -$59.8M -- -$48.5M -$43.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.5M $48.4K -- -$6.6M $7.1M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $73.3K $570K -- -$2.5K -$543.9K
Net Income to Common Excl Extra Items $10.3M -$59.2M -- -$41.8M -$51M
 
Basic EPS (Cont. Ops) $0.38 -$2.08 -- -$1.52 -$1.69
Diluted EPS (Cont. Ops) $0.38 -$2.08 -- -$1.52 -$1.69
Weighted Average Basic Share $28.5M $28.6M -- $29.9M $30.3M
Weighted Average Diluted Share $28.5M $28.6M -- $29.9M $30.3M
 
EBITDA -$11.2M -$8M -- -$8.5M -$7.5M
EBIT -$11.2M -$8M -- -$8.5M -$7.5M
 
Revenue (Reported) $40M $27.9M -- $23.2M $33M
Operating Income (Reported) -$11.2M -$8M -- -$8.5M -$7.5M
Operating Income (Adjusted) -$11.2M -$8M -- -$8.5M -$7.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $224M $121.5M $128.1M $94.7M $112.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $68.7M $39.9M -- $32.8M $37.5M
Gross Profit $155.2M $81.6M -- $61.9M $75M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $65.6M $32.7M -- $25.2M $33.9M
Selling, General & Admin $165.1M $87.1M -- $66.8M $80.8M
Other Inc / (Exp) $144.2M -$21.6M -- -$68.6M -$43.7M
Operating Expenses $231.6M $117.1M -- $91.6M $114.6M
Operating Income -$76.4M -$35.5M -- -$29.7M -$39.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $72.9M -$53.2M -- -$89.6M -$77.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $13.6M $2.1M -- -$6.1M $6.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $784.6K $327.6K -- -$1.3M -$2.2M
Net Income to Common Excl Extra Items $60.1M -$54.9M -- -$84.8M -$85.9M
 
Basic EPS (Cont. Ops) $2.09 -$1.92 -- -$2.98 -$2.89
Diluted EPS (Cont. Ops) $2.09 -$1.92 -- -$2.98 -$2.89
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$76.4M -$35.5M -- -$29.7M -$39.6M
EBIT -$76.4M -$35.5M -- -$29.7M -$39.6M
 
Revenue (Reported) $224M $121.5M $128.1M $94.7M $112.4M
Operating Income (Reported) -$76.4M -$35.5M -- -$29.7M -$39.6M
Operating Income (Adjusted) -$76.4M -$35.5M -- -$29.7M -$39.6M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $121.5M -- $94.7M $112.4M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $39.9M -- $32.8M $37.5M --
Gross Profit $81.6M -- $61.9M $75M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $32.7M -- $25.2M $33.9M --
Selling, General & Admin $87.1M -- $66.8M $80.8M --
Other Inc / (Exp) -$21.6M -- -$68.6M -$43.7M --
Operating Expenses $117.1M -- $91.6M $114.6M --
Operating Income -$35.5M -- -$29.7M -$39.6M --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$53.2M -- -$89.6M -$77.1M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.1M -- -$6.1M $6.6M --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $327.6K -- -$1.3M -$2.2M --
Net Income to Common Excl Extra Items -$54.9M -- -$84.8M -$85.9M --
 
Basic EPS (Cont. Ops) -$1.92 -- -$2.98 -$2.89 --
Diluted EPS (Cont. Ops) -$1.92 -- -$2.98 -$2.89 --
Weighted Average Basic Share $114.4M -- $117.8M $120.2M --
Weighted Average Diluted Share $114.6M -- $117.8M $120.2M --
 
EBITDA -$35.5M -- -$29.7M -$39.6M --
EBIT -$35.5M -- -$29.7M -$39.6M --
 
Revenue (Reported) $121.5M -- $94.7M $112.4M --
Operating Income (Reported) -$35.5M -- -$29.7M -$39.6M --
Operating Income (Adjusted) -$35.5M -- -$29.7M -$39.6M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $198.9M $248.5M $219.7M $285M $251.1M
Short Term Investments $55.2M $41.2M $22.6M $144.3K $45.9K
Accounts Receivable, Net $34.5M $26.7M $41.1M $56.6M $64.9M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $127.9M $75.2M $140.3M $137.3M $187.1M
Total Current Assets $451.1M $407.7M $452.8M $489.1M $517.8M
 
Property Plant And Equipment $18.3M $23.1M $14.2M $11.9M $10.7M
Long-Term Investments $368.8M $312.9M $259.8M $132.2M $112M
Goodwill -- -- -- $81.4M $58.1M
Other Intangibles $1.9M $1.6M $1.2M $30.8M $26.1M
Other Long-Term Assets $16.1M $16.1M $13.5M $22.6M $11.8M
Total Assets $859.2M $781M $744.9M $794.7M $754M
 
Accounts Payable $16.2M $21.2M $19.3M $24M $30.1M
Accrued Expenses $38.8M $31.4M $39.8M $62.6M $377.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.1M $2.7M $2.1M $1.9M --
Other Current Liabilities $11.6M $8.7M $9.3M $9.7M --
Total Current Liabilities $240.7M $212.4M $257.8M $384.9M $422.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $279.4M $253.9M $294.9M $419.4M $451.7M
 
Common Stock $35.8K $36.9K $34.2K $34.4K $34K
Other Common Equity Adj $25M $13.8M $51.3M $50.3M $56.2M
Common Equity $573.6M $514.4M $439.7M $346.5M $260.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.3M $12.7M $10.4M $28.9M $42M
Total Equity $579.9M $527.2M $450M $375.3M $302.3M
 
Total Liabilities and Equity $859.2M $781M $744.9M $794.7M $754M
Cash and Short Terms $254.2M $289.7M $242.3M $285.1M $251.1M
Total Debt -- -- -- $705.4K --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $198.9M $248.5M $219.7M $285M $251.1M
Short Term Investments $55.2M $41.2M $22.6M $144.3K $45.9K
Accounts Receivable, Net $34.5M $26.7M $41.1M $56.6M $64.9M
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $127.9M $75.2M $140.3M $137.3M $187.1M
Total Current Assets $451.1M $407.7M $452.8M $489.1M $517.8M
 
Property Plant And Equipment $18.3M $23.1M $14.2M $11.9M $10.7M
Long-Term Investments $368.8M $312.9M $259.8M $132.2M $112M
Goodwill -- -- -- $81.4M $58.1M
Other Intangibles $1.9M $1.6M $1.2M $30.8M $26.1M
Other Long-Term Assets $16.1M $16.1M $13.5M $22.6M $11.8M
Total Assets $859.2M $781M $744.9M $794.7M $754M
 
Accounts Payable $16.2M $21.2M $19.3M $24M $30.1M
Accrued Expenses $38.8M $31.4M $39.8M $62.6M $377.6M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.1M $2.7M $2.1M $1.9M --
Other Current Liabilities $11.6M $8.7M $9.3M $9.7M --
Total Current Liabilities $240.7M $212.4M $257.8M $384.9M $422.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $279.4M $253.9M $294.9M $419.4M $451.7M
 
Common Stock $35.8K $36.9K $34.2K $34.4K $34K
Other Common Equity Adj $25M $13.8M $51.3M $50.3M $56.2M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.3M $12.7M $10.4M $28.9M $42M
Total Equity $579.9M $527.2M $450M $375.3M $302.3M
 
Total Liabilities and Equity $859.2M $781M $744.9M $794.7M $754M
Cash and Short Terms $254.2M $289.7M $242.3M $285.1M $251.1M
Total Debt -- -- -- $705.4K --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$54.1M $59.6M -$54.7M -$77.5M -$84M
Depreciation & Amoritzation $9.5M $9.9M $7.9M $7.9M $5M
Stock-Based Compensation $18.4M $11.7M $1.1M $1.2M $4.7M
Change in Accounts Receivable $18.9M $18.8M $19.5M -$12.8M -$20.8M
Change in Inventories -- -- -- -- --
Cash From Operations -$34.7M -$6.7M $15.9M -$63.2M $77.8M
 
Capital Expenditures $14.8M $8.6M $7.3M $1M $1.4M
Cash Acquisitions -$37.9M $23.2M $7M -- -$33.7M
Cash From Investing -$157.1M $272.5M $34.2M $28.1M -$6.9M
 
Dividends Paid (Ex Special Dividend) -$72.5M -$208M -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $10.2M -- -- --
Long-Term Debt Repaid -- -$9.5M -- -- --
Repurchase of Common Stock -$25.3K -- -- -- --
Other Financing Activities -$187.9K -$3.2M -$777.5K -- -$128.5K
Cash From Financing -$70.2M -$210.2M -$1.5M -$724.4K -$958.2K
 
Beginning Cash (CF) $403.9M $142.8M $201.4M $235.9M $214.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$262M $55.6M $48.6M -$35.7M $69.9M
Ending Cash (CF) $142.7M $188.4M $245.4M $225.8M $285.6M
 
Levered Free Cash Flow -$49.5M -$15.3M $8.7M -$64.2M $76.5M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-04-01 2022-04-01 2023-04-01 2024-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is down 14.04% over the past day.

Sell
16
PCVX alert for Apr 1

Vaxcyte [PCVX] is down 3.13% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is down 6.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock